Shumei Song Selected Research

Neoplasms (Cancer)

11/2023	Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases.
6/2023	Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases.
6/2023	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.
1/2023	Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
12/2021	Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.
11/2021	Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
1/2021	Drug resistance and Cancer stem cells.
12/2020	The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.
11/2020	Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.
10/2020	LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shumei Song Research Topics

Disease

39	Neoplasms (Cancer) 11/2023 - 08/2004
19	Adenocarcinoma 06/2021 - 11/2007
12	Stomach Neoplasms (Stomach Cancer) 12/2023 - 04/2014
9	Carcinogenesis 04/2024 - 01/2002
9	Neoplasm Metastasis (Metastasis) 11/2023 - 08/2004
9	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 01/2002
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2005
4	Breast Neoplasms (Breast Cancer) 08/2017 - 08/2004
3	Ascites 12/2023 - 12/2020
3	Peritoneal Neoplasms 11/2023 - 01/2021
3	Colonic Neoplasms (Colon Cancer) 12/2020 - 11/2005
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 11/2016
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2018 - 11/2016
2	Barrett Esophagus (Barrett's Esophagus) 08/2011 - 06/2011
1	Testicular Neoplasms (Testicular Cancer) 06/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2022
1	Poisoning 12/2022
1	Peritoneal Diseases 01/2021
1	Chromosomal Instability (Chromosome Stability) 12/2020
1	Polyps 12/2020
1	Microsatellite Instability 12/2020
1	Bites and Stings (Sting) 11/2020
1	Lymphatic Metastasis 10/2020
1	Genomic Instability 01/2019
1	Circulating Neoplastic Cells 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 08/2017
1	Melanoma (Melanoma, Malignant) 08/2017
1	Pathologic Complete Response 12/2014

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2005
6	Galectin 3 (LGALS3)IBA 11/2023 - 11/2005
5	Long Noncoding RNAIBA 03/2021 - 11/2016
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2015
4	Messenger RNA (mRNA)IBA 06/2023 - 01/2002
3	Phosphotransferases (Kinase)IBA 06/2023 - 04/2005
3	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2020
3	MicroRNAs (MicroRNA)IBA 01/2018 - 02/2013
3	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 06/2015
3	Small Interfering RNA (siRNA)IBA 01/2017 - 02/2009
3	Complementary DNA (cDNA)IBA 03/2009 - 11/2005
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2020
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2021 - 08/2020
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2017 - 02/2009
2	RamucirumabIBA 08/2017 - 04/2014
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2009 - 01/2002
2	Bile Acids and Salts (Bile Acids)IBA 11/2007 - 04/2005
2	MucinsIBA 11/2005 - 04/2005
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2005 - 04/2005
2	Peptides (Polypeptides)IBA 02/2005 - 08/2004
1	Cadherins (E-Cadherin)IBA 04/2024
1	Epithelial Cell Adhesion MoleculeIBA 12/2023
1	AntigensIBA 06/2023
1	HerbicidesIBA 12/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2022
1	ParaquatIBA 12/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022
1	gossypol acetic acidIBA 12/2021
1	Aurora Kinase BIBA 12/2020
1	AzoxymethaneIBA 12/2020
1	Dextran SulfateIBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	A-Form DNA (A-DNA)IBA 11/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2020
1	GW 501516IBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	3' Untranslated Regions (3' UTR)IBA 01/2020
1	AZD5153IBA 01/2019
1	Deoxyribonuclease I (Nickase)IBA 01/2019
1	ribociclibIBA 01/2019
1	CytokinesIBA 01/2018
1	ChemokinesIBA 01/2018
1	Circulating Tumor DNAIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Insulin-Like PeptidesIBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	TOR Serine-Threonine KinasesIBA 11/2017
1	Oncogene Proteins (Oncogene Protein)IBA 08/2017
1	prexasertibIBA 01/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2017
1	talazoparibIBA 01/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 11/2016
1	Transcriptional Coactivator with PDZ-Binding Motif ProteinsIBA 11/2016
1	Untranslated RNA (Noncoding RNA)IBA 11/2016
1	navitoclaxIBA 09/2015
1	Metformin (Glucophage)FDA LinkGeneric 08/2014

Therapy/Procedure

27	Therapeutics 11/2023 - 08/2004
6	Drug Therapy (Chemotherapy) 01/2021 - 08/2014
3	Hyperthermic Intraperitoneal Chemotherapy 01/2021 - 08/2020
2	Gastrectomy 01/2021 - 09/2018
1	Immunotherapy 06/2023
1	Lung Transplantation 12/2022
1	Extracorporeal Membrane Oxygenation 12/2022
1	Noninvasive Ventilation 12/2022
1	Radiotherapy 11/2016
1	Neoadjuvant Therapy 12/2014
1	Chemoradiotherapy 10/2014
1	Adjuvant Chemotherapy 10/2014
1	Duration of Therapy 04/2014